Express Pharma
Express Pharma
Browsing tag
Gilead Sciences
Gilead may soon buy Immunomedics in deal over $20 billion
Read more
Gilead and Jounce Therapeutics sign exclusive license pact for novel immunotherapy program
Read more
Remdesivir has only marginal benefit for moderate COVID-19 patients
Read more
US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
Read more
Gilead seeks full approval for remdesivir from US FDA for COVID-19 treatment
Read more
Pfizer signs agreement with Gilead Sciences to manufacture remdesivir
Read more
Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed
Read more
Gilead begins testing inhalable form of remdesivir for COVID-19
Read more
Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations
Read more
Gilead to buy 49.9 per cent stake in cancer drug developer for $275 million
Read more
Posts navigation
Previous
Page 1 of 6
…
Page 3 of 6
…
Page 6 of 6
Next